168
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Immunity and inflammation predictors for short-term outcome of stroke in young adults

, , , , , & show all
Pages 634-639 | Received 28 Mar 2017, Accepted 17 Nov 2017, Published online: 12 Dec 2017

References

  • Feigin VL, Lawes CM, Bennett DA, et al. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review [review]. Lancet Neurol. 2009;8(4):355–369.
  • Nedeltchev K, der Maur TA, Georgiadis D, et al. Ischaemic stroke in young adults: predictors of outcome and recurrence. J Neurol Neurosurg Psychiatry. 2005;76(2):191–195.
  • Rutten-Jacobs LC, Maaijwee NA, Arntz RM, et al. Risk factors and prognosis of young stroke. The FUTURE study: a prospective cohort study. Study rationale and protocol. BMC Neurol. 2011;11:109.
  • Putaala J, Metso AJ, Metso TM, et al. Analysis of 1008 consecutive patients aged 15–49 with first-ever ischemic stroke: the Helsinki young stroke registry. Stroke. 2009;40(4):1195–1203.
  • Varona JF, Bermejo F, Guerra JM, et al. Long-term prognosis of ischemic stroke in young adults. Study of 272 cases. J Neurol. 2004;251(12):1507–1514.
  • Radhakrishnan K, Ashok PP, Sridharan R, et al. Stroke in the young: incidence and pattern in Benghazi, Libya. Acta Neurol Scand. 1986;73(4):434–438.
  • Nencini P, Inzitari D, Baruffi MC, et al. Incidence of stroke in young adults in Florence, Italy. Stroke. 1988;19(8):977–981.
  • Kittner SJ, McCarter RJ, Sherwin RW, et al. Black-white differences in stroke risk among young adults. Stroke. 1993;24(12 Suppl):I13–I15. (I20-1).
  • Ferro JM, Massaro AR, Mas JL. Aetiological diagnosis of ischaemic stroke in young adults [review]. Lancet Neurol. 2010;9(11):1085–1096.
  • Anrather J, Iadecola C. Inflammation and stroke: An overview [review]. Neurotherapeutics. 2016;13(4):661–670.
  • Hakkennes SJ, Brock K, Hill KD. Selection for inpatient rehabilitation after acute stroke: a systematic review of the literature [review]. Arch Phys Med Rehabil. 2011;92(12):2057–2070.
  • Koton S, Tanne D, Green MS, et al. Mortality and predictors of death 1 month and 3 years after first-ever ischemic stroke: data from the first National Acute Stroke Israeli Survey (NASIS 2004). Neuroepidemiology. 2010;34(2):90–96.
  • Saposnik G, Hill MD, O'Donnell M, et al. Variables associated with 7-day, 30-day, and 1-year fatality after ischemic stroke. Stroke. 2008;39(8):2318–2324.
  • Andersen KK, Andersen ZJ, Olsen TS. Predictors of early and late case-fatality in a nationwide Danish study of 26,818 patients with first-ever ischemic stroke. Stroke. 2011;42(10):2806–2812.
  • Liu L, Wang D, Wong KS, et al. Stroke and stroke care in China: huge burden, significant workload, and a national priority [review]. Stroke. 2011;42(12):3651–3654.
  • Johnston SC, Mendis S, Mathers CD. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. Lancet Neurol. 2009;8(4):345–354.
  • Sene DF, Basse AM, Toure K, et al. Prognosis of stroke in department of neurology of Dakar [English abstract]. Dakar Med. 2006;51(1):17–21.
  • Gonzalez HA, Fabre PO, Lopez FJ, et al. Risk factors, etiology and prognosis in patients older than 80 years old with ischemic stroke [English abstract]. Rev Esp Geriatr Gerontol. 2008;43(6):366–369.
  • den Hertog HM, van Rossum JA, van der Worp HB, et al. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol. 2009;256(12):2003–2008.
  • Shantikumar S, Grant PJ, Catto AJ, et al. Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation [letter]. Stroke. 2009;40(3):977–979.
  • Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001;32(4):917–924.
  • Lyden P, Brott T, Tilley B, et al. Improved reliability of the NIH Stroke Scale using video training. NINDS TPA Stroke Study Group. Stroke. 1994;25(11):2220–2226.
  • Muchada M, Rubiera M, Rodriguez-Luna D, et al. Baseline national institutes of health stroke scale-adjusted time window for intravenous tissue-type plasminogen activator in acute ischemic stroke. Stroke. 2014;45(4):1059–63.
  • Adams HJ, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41.
  • van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607.
  • Sulter G, Steen C, De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke. 1999;30(8):1538–1541.
  • Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17(7):796–808.
  • Pusch G, Debrabant B, Molnar T, et al. Early dynamics of P-selectin and interleukin 6 predicts outcomes in ischemic stroke. J Stroke Cerebrovasc Dis. 2015;24(8):1938–1947.
  • Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments [review]. Neuron. 2010;67(2):181–198.
  • Audebert HJ, Rott MM, Eck T, et al. Systemic inflammatory response depends on initial stroke severity but is attenuated by successful thrombolysis. Stroke. 2004;35(9):2128–2133.
  • Kazmierski R, Guzik P, Ambrosius W, et al. Predictive value of white blood cell count on admission for in-hospital mortality in acute stroke patients. Clin Neurol Neurosurg. 2004;107(1):38–43.
  • Yoon SS, Zheng Z. Elevated total white blood cell count with high blood glucose is associated with poor outcome after ischemic stroke. J Stroke Cerebrovasc Dis. 2005;14(2):88–93.
  • Worthmann H, Tryc AB, Deb M, et al. Linking infection and inflammation in acute ischemic stroke [review]. Ann N Y Acad Sci. 2010;1207:116–122.
  • Arboix A, Vall-Llosera A, Garcia-Eroles L, et al. Clinical features and functional outcome of intracerebral hemorrhage in patients aged 85 and older. J Am Geriatr Soc. 2002;50(3):449–454.
  • Shi YZ, Wang CX, Li JJ, et al. Acute ischemic stroke in the very elderly outcome and predictive factors [English abstract]. Chinese J Intern Med. 2012;51(5):343–346.
  • Lemkine GF, Raj A, Alfama G, et al. Adult neural stem cell cycling in vivo requires thyroid hormone and its alpha receptor. Faseb J. 2005;19(7):863–865.
  • Cramer SC. Repairing the human brain after stroke: I. Mechanisms of spontaneous recovery [review]. Ann Neurol. 2008;63(3):272–287.
  • Sui L, Ren WW, Li BM. Administration of thyroid hormone increases reelin and brain-derived neurotrophic factor expression in rat hippocampus in vivo. Brain Res. 2010;1313:9–24.
  • Kolb B, Cote S, Ribeiro-da-Silva A, et al. Nerve growth factor treatment prevents dendritic atrophy and promotes recovery of function after cortical injury. Neuroscience. 1997;76(4):1139–51.
  • Arboix A, Estevez S, Rouco R, et al. Clinical characteristics of acute lacunar stroke in young adults. Expert Rev Neurother. 2015;15(7):825–831.
  • Arboix A, Marti-Vilalta JL. Lacunar stroke [review]. Expert Rev Neurother. 2009;9(2):179–196.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.